Revenue from pharma tests, enterprise sales, and other customers in the range of $15 to $16 million; Revenue from population sequencing is expected to be zero due to completion of the prior VA MVP task order
Revenue from pharma tests, enterprise sales, and other customers in the range of $15 to $16 million; Revenue from population sequencing is expected to be zero due to completion of the prior VA MVP task order